Study: PET imaging with FAC may improve treatment of liposarcoma

01/8/2013 | Oncology Nurse Advisor online

PET imaging with a tracer called FAC allowed for the detection of nucleoside salvage activity in liposarcoma tumor cells, according to a study published in the journal Cancer Discovery. The study also discovered liposarcoma cells with high nucleoside salvage activity are susceptible to the standard chemotherapy drug gemcitabine. The findings indicate the PET imaging strategy may improve identification of patients who would likely respond to gemcitabine treatment.

View Full Article in:

Oncology Nurse Advisor online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC